Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

St. Jude Children's Research Hospital

14 clinical trials · 14 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by St. Jude Children's Research Hospital

RECRUITINGNCT03050268

Familial Investigations of Childhood Cancer Predisposition

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many...

Sponsor: St. Jude Children's Research HospitalEnrolling: 15001 location
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43
RECRUITINGPhase 1NCT06326463

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

The study participant has one of the following blood cancers: acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (B-ALL, T-ALL) or...

Sponsor: St. Jude Children's Research HospitalEnrolling: 181 location
Hematologic MalignancyALL, ChildhoodAML, Childhood+2
RECRUITINGPhase 1 / Phase 2NCT04901702

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

The phase I portion of this study is designed for children or adolescents and young adults (AYA) with a diagnosis of a solid tumor that has recurred (come back after treatment) or...

Sponsor: St. Jude Children's Research HospitalEnrolling: 9010 locations
Recurrent Solid TumorRecurrent Ewing SarcomaRecurrent Hepatoblastoma+19
RECRUITINGPhase 2NCT06023641

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based...

This is a phase II study to determine safety and efficacy of combining liposomal irinotecan with vincristine alternating with VAC in intermediate-risk patients, liposomal...

Sponsor: St. Jude Children's Research HospitalEnrolling: 1353 locations
Rhabdomyosarcoma
RECRUITINGPhase 1 / Phase 2NCT06239272

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and...

The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free survival for...

Sponsor: St. Jude Children's Research HospitalEnrolling: 1396 locations
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6
RECRUITINGNCT06477289

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

This study will examine sleep disordered breathing and sleep quality in participants (ages 12-18) diagnosed with sickle cell disease of any genotype. We will utilize remote...

Sponsor: St. Jude Children's Research HospitalEnrolling: 651 location
Sickle Cell Disease
RECRUITINGPhase 1NCT07226219

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to...

Sponsor: St. Jude Children's Research HospitalEnrolling: 721 location
Sickle Cell DiseaseExecutive DysfunctionCognitive Impairment+1
RECRUITINGNCT05384288

Response to Influenza Vaccination in Pediatric Oncology Patients

Influenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower...

Sponsor: St. Jude Children's Research HospitalEnrolling: 1501 location
Hematologic MalignancyPediatric CancerTransplant-Related Cancer
RECRUITINGNCT04416178

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

The primary objectives of this prospective mixed-method interview study are to use semi-structured interviews in parents of sickle cell disease (SCD) patients to describe parental...

Sponsor: St. Jude Children's Research HospitalEnrolling: 3521 location
Sickle Cell Disease
RECRUITINGNCT05810181

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

This prospective mixed-method interview study aims to qualitatively describe the beliefs, attitudes, and informational needs around gene therapy for rare pediatric diseases among...

Sponsor: St. Jude Children's Research HospitalEnrolling: 701 location
Sickle Cell Disease
RECRUITINGPhase 1NCT06442761

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

This study is being done to see if the study drug, motixafortide, is safe in participants with sickle cell disease (SCD). Investigators also want to see if the drug will help the...

Sponsor: St. Jude Children's Research HospitalEnrolling: 152 locations
Sickle Cell Disease
RECRUITINGPhase 1NCT06506461

Gene Editing For Sickle Cell Disease

This study is being done to test the safety of a new treatment called gene editing in Sickle Cell Disease (SCD) patients and to see if a single dose of this genetically modified...

Sponsor: St. Jude Children's Research HospitalEnrolling: 251 location
Sickle Cell Disease
RECRUITINGNCT02720679

Investigation of the Genetics of Hematologic Diseases

The purpose of this study is to collect and store samples and health information for current and future research to learn more about the causes and treatment of blood diseases....

Sponsor: St. Jude Children's Research HospitalEnrolling: 17161 location
Bone Marrow Failure SyndromesErythrocyte DisorderLeukocyte Disorder+10
RECRUITINGNCT06532474

Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular...

In this observational study, researchers are looking at the effects of spinal muscular atrophy (SMA) drugs on the muscles and nerve cells in patients with SMA. Primary Objectives...

Sponsor: St. Jude Children's Research HospitalEnrolling: 241 location
Spinal Muscular Atrophy